CClinicalTrials.gg
Status unknownNCT00852982SMIDIGUpdated Mar 2, 2009

Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons

An interventional study of Exercise in Type 2 Diabetes and Impaired Glucose Tolerance, sponsored by Karolinska Institutet. Status unknown at 1 site in Sweden. Open to participants aged 45 Years to 69 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-03-02.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Feb 2009), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
213
Allocation
Randomized
Ages
45 Years to 69 Years
Sex
All
01

Study summary

A sedentary lifestyle is known to be a risk factor to developing type 2 diabetes. The aim of this study was to determine the effects of adding regular Nordic walking to daily physical activity. Effects on quality of life, cardiovascular risk factors and functions in muscle cells will be determined.

Read the detailed description

Regular physical activity is known to have a beneficial effect on several factors affecting the risk of developing cardiovascular disease and type 2 diabetes. Implementing and maintaining changes of lifestyle is, however, known to be difficult. In this study we wished to investigate the effects of an exercise intervention that is feasible to most people with type 2 diabetes or at risk of developing that disease. The intervention was Nordic walking (with walking poles) for five hour per week, during four months. We chose to determine effects on health related quality of life, clinical parameters related to body weight/body composition, blood pressure, glucose metabolism, insulin resistance, blood lipids, oxygen uptake and physiological effects in skeletal muscle cells related to glucose metabolism.

On inclusion and after four months the participants were therefore subject to clinical measurements, blood samples, maximal oxygen uptake tests on an ergometer cycle and muscle biopsies at inclusion and after four months of participation. They also answered an extensive questionnaire focusing on health related quality of life.

02

Conditions studied

  • Type 2 Diabetes
  • Impaired Glucose Tolerance

Keywords

  • Exercise
  • Risk factors
  • Primary health care
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 213 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI>25

Exclusion criteria

Exclusion Criteria:

  • Physical impairment
  • Symptomatic angina pectoris
  • Insulin treatment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
213 participants (estimated)

Study arms

  • Experimental
    Exercise

    Five hours of Nordic walking per week, during four months

    Behavioral: Exercise

  • No intervention
    Control

    Control group asked not to alter lifestyle during study

    Behavioral: Exercise

Interventions

  • BehavioralExercise

    Nordic walking, with walking poles, five hours per week during four months

06

What researchers measure

Primary outcomes

  1. HbA1c

    Time frame: at inclusion and after four months

Secondary outcomes

  1. waist circumference

    Time frame: at inclusion and after four months

07

Study locations

1 site
  • Primary health care center
    Stockholm, SE 134 40, Sweden
08

References and documents

Publications

  • Osler ME, Fritz T, Caidahl K, Krook A, Zierath JR, Wallberg-Henriksson H. Changes in gene expression in responders and nonresponders to a low-intensity walking intervention. Diabetes Care. 2015 Jun;38(6):1154-60. doi: 10.2337/dc14-2606. Epub 2015 Mar 20. PubMed 25795414 ↗
  • Fritz T, Caidahl K, Osler M, Ostenson CG, Zierath JR, Wandell P. Effects of Nordic walking on health-related quality of life in overweight individuals with type 2 diabetes mellitus, impaired or normal glucose tolerance. Diabet Med. 2011 Nov;28(11):1362-72. doi: 10.1111/j.1464-5491.2011.03348.x. PubMed 21658122 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00852982
Lead sponsor
Karolinska Institutet
First posted
Feb 27, 2009
Start date
Apr 2006
Primary completion
Sep 2009 (estimated)
Completion
Sep 2009 (estimated)
Last update
Mar 2, 2009

Study contacts

Juleen Zierath, Professor
principal investigator · Dep. of molecular medicine and surgery, Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion